hepat
b
viru
hbv
infect
remain
global
health
problem
often
lead
sever
consequ
liver
failur
fibrosi
cirrhosi
hepatocellular
carcinoma
hcc
billion
peopl
infect
hbv
million
peopl
lifelong
patient
immun
therapi
effect
measur
new
infect
million
hbv
patient
eventu
succumb
infect
sequenc
due
vaccin
failur
interferona
polyethylen
glycol
interferona
use
antihbv
agent
clinic
howev
applic
limit
low
cure
rate
seriou
side
effect
influenzalik
symptom
fatigu
myalgia
nausea
headach
etc
five
nucleosid
drug
lamivudin
adefovir
dipivoxil
adv
entecavir
etv
telbivudin
ldt
tenofovirdf
tdf
approv
fda
hbv
treatment
disadvantag
nucleosid
drug
resist
high
recurr
becom
import
clinic
issu
singl
target
new
strategi
aim
viral
suppress
promot
virolog
clearanc
prevent
drug
resist
fascin
topic
therefor
novel
antihbv
agent
uniqu
antivir
target
mechan
still
need
natur
product
deriv
simpl
functionalgroup
transform
offer
mani
opportun
find
novel
antihbv
lead
drug
uniqu
antivir
mechan
exampl
helioxanthin
initi
isol
shrub
taiwania
cryptomerioid
uniqu
mechan
diminish
hbv
promot
activ
block
viral
gene
express
replic
chemic
modif
activ
deriv
fig
obtain
oxymatrin
fig
deriv
show
antihbv
activ
suppress
host
heatstress
cognat
express
previou
studi
alisol
alisma
orientali
possess
potent
antihbv
activ
seri
highact
deriv
obtain
fig
chemic
modif
ongo
search
potenti
antihbv
inhibitor
latest
studi
reveal
caudatin
fig
cynanchum
auriculatum
baishouwu
chines
activ
inhibit
secret
hbsag
hbv
dna
replic
ic
valu
mm
si
mm
si
respect
furthermor
caudatin
prospect
antihcc
drug
mechan
inhibit
cell
prolifer
induc
cell
apoptosi
report
consequ
may
interest
caudatin
develop
novel
antihbv
agent
chemic
modif
cinnam
acid
analog
ester
amid
glycosid
attract
much
attent
biolog
medicin
antivir
antiatherogen
antitumor
antituberculosi
antioxid
antibacteri
properti
exampl
cinnam
acid
fig
could
inhibit
hivsarscov
pseudoviru
cholesteryl
conjug
cimmam
acid
fig
could
enhanc
antipolioviru
type
activ
caffeic
acid
acid
fig
chlorogen
acid
ester
acid
quinic
acid
fig
show
potent
antihbv
activ
vivo
vitro
suggest
molecular
cinnam
acid
moieti
might
show
potent
antihbv
activ
meanwhil
cinnam
acid
wide
appli
food
addit
good
safeti
molecular
hybrid
two
pharmacophor
often
lead
synergist
activ
thu
combin
caudatin
cinnam
acid
novel
antihbv
agent
design
anticip
hybrid
could
enhanc
antihbv
activ
decreas
cytotox
herein
report
chemic
modif
hbv
inhibitori
properti
caudatin
deriv
design
molecular
hybrid
activ
compound
investig
mechan
action
hbv
promot
x
promot
enhanc
eni
enii
well
acut
toxic
mice
compound
synthes
reaction
correspond
cinnam
acid
caudatin
presenc
n
n
dicyclohexylcarbodiimid
dcc
dmap
scheme
except
compound
obtain
start
caudatin
acid
presenc
diisopropyl
azodicarboxyl
diad
triphenylphosphin
tpp
scheme
gener
introduct
fluorin
use
alter
physic
properti
bind
characterist
metabol
disposit
develop
drug
lead
thu
variou
fluorin
cinnam
acid
use
react
caudatin
structur
synthes
deriv
tabl
identifi
spectroscop
mean
h
c
nmr
ms
structur
caudatin
deriv
determin
comparison
caudatin
andor
monocinnamoyl
analog
caudatin
deriv
test
antihbv
activ
name
inhibit
secret
hbsag
hbeag
hbv
dna
replic
hepg
cell
data
antihbv
activ
cytotox
list
tabl
deriv
effect
inhibit
hbsag
hbeag
secret
hbv
dna
replic
caudatin
ic
valu
si
valu
respect
methyl
group
introduc
cinnamoyl
moieti
antihbv
activ
compound
slightli
decreas
compar
compound
still
greater
caudatin
introduct
formyl
group
cinnamoyl
moieti
compound
could
increas
antihbv
activ
secret
hbsag
hbeag
hbv
dna
replic
cytotox
cc
hydroxyl
group
introduc
cinnamoyl
activ
cytotox
compound
increas
compound
exhibit
greater
activ
weaker
cytotox
compound
hydroxi
cinnamoyl
replac
alkoxyl
group
meoe
eto
eoch
oe
cinnamoyl
caudatin
possess
highest
activ
inhibit
secret
hbsag
ic
si
hbeag
ic
si
also
hbv
dna
replic
ic
si
antihbv
activ
cytotox
deriv
increas
compar
caudatin
acetoxi
group
incorpor
cinnam
acid
moieti
introduct
halogen
atom
caudatin
deriv
could
significantli
enhanc
antihbv
activ
fluorin
atom
deriv
led
cytotox
cc
cc
increas
compound
one
cf
group
show
potent
activ
hbsag
secret
hbvdna
replic
weaker
hbeag
secret
coexist
cf
group
cinnamoyl
remark
decreas
antihbv
activ
antihbv
activ
compound
nitro
group
substitut
cinnamoyl
group
increas
cytotox
decreas
posit
substitu
cinnamoyl
moieti
could
impact
antihbv
activ
caudatin
deriv
substitut
methyl
vs
alkoxi
vs
vs
f
vs
cl
vs
br
vs
metasubstitut
analog
show
greater
activ
orthoand
parasubstitut
contrari
activ
metasubstitut
weaker
orthoand
parasubstitut
substitu
trifluoromethyl
vs
nitro
vs
group
result
propos
small
substitut
could
affect
steric
clash
electron
densiti
hydrogenbond
capac
result
differ
antihbv
activ
caudatin
deriv
due
good
activ
conjug
deriv
caudatin
one
cinnamoyl
moieti
caudatin
deriv
synthes
disappointedli
antihbv
activ
compound
obvious
decreas
result
indic
free
hydroxyl
group
caudatin
essenti
antihbv
activ
steroid
skeleton
play
crucial
role
maintain
antihbv
activ
conjug
ester
elucid
mechan
action
luciferas
report
gene
assay
use
determin
effect
compound
hbv
promot
x
promot
enhanc
eni
enii
result
compound
luciferas
report
assay
shown
fig
cell
viabil
h
h
respect
accord
mtt
assay
compound
mainli
inhibit
time
transcript
activ
hbv
x
promot
xp
increas
time
hbv
enhanc
eni
compar
mocktreat
control
hbv
sequenc
transcrib
control
promot
enhanc
import
replic
hbv
xp
regul
transcript
small
kb
mrna
sequenc
encod
hbv
x
protein
hbx
play
import
role
stimul
hbv
transcript
replic
hbv
eni
element
take
crucial
effect
overal
liverspecif
regul
hbv
gene
express
thu
compound
might
exert
antihbv
activ
interf
promot
enhanc
influenc
hbv
transcript
consid
nucleotid
overlap
minim
xp
sequenc
end
eni
compound
presum
simultan
influenc
xp
eni
overlap
region
studi
need
clarifi
compound
take
effect
region
respond
exactli
nucleosid
analog
suppress
hbv
replic
inhibit
hbv
polymeras
termin
prematur
dna
chain
directli
affect
hbv
gene
express
compound
exhibit
antihbv
activ
interf
hbv
gene
express
instead
inhibit
hbv
dna
polymeras
differ
nucleosid
analog
evalu
safeti
compound
acut
toxic
test
mice
group
healthi
kunm
mice
gender
oral
administr
compound
singl
dose
mgkg
respect
surviv
abnorm
mice
monitor
day
post
administr
die
abnorm
observ
includ
bodi
weight
tabl
mice
throughout
observ
period
demonstr
compound
good
safeti
vivo
ld
valu
mgkg
oral
rout
summari
design
synthesi
led
seri
nonnucleosid
antihbv
agent
attach
cinnam
acid
caudatin
deriv
display
potent
antihbv
activ
especi
inhibit
hbv
dna
replic
preliminari
mechan
studi
propos
compound
exert
antiviru
effect
via
interf
hbv
promot
enhanc
influenc
hbv
transcript
low
cytotox
acut
toxic
mice
indic
compound
may
potenti
novel
nonnucleosid
antihbv
drug
candid
uniqu
mechan
investig
nuclear
magnet
reson
nmr
spectra
record
bruker
h
c
mhz
h
c
mhz
spectromet
chemic
shift
given
ppm
tm
intern
standard
bruker
bremerhaven
germani
ms
hrm
spectra
determin
autospec
premier
vg
manchest
uk
api
qstar
pulsar
ab
foster
citi
usa
mass
spectromet
column
chromatographi
cc
silica
gel
mesh
qingdao
makal
group
co
ltd
qingdao
china
reaction
monitor
use
thinlay
chromatographi
tlc
silica
gel
plate
caudatin
isol
c
auriculatum
baishouwu
puriti
substitut
cinnam
acid
purchas
alfa
aesar
j
k
scientif
ltd
organ
solvent
analyt
reagent
grade
purchas
tianjin
chemic
reagent
co
ltd
solut
mmol
dmap
equiv
proper
cinnam
acid
equiv
anhydr
ch
cl
ml
ad
hz
promot
region
hbv
core
nucleotid
nt
x
nt
pre
nt
nt
eni
enii
clone
upstream
luciferas
gene
promega
respect
hepg
transient
transfect
report
vector
dish
use
accord
manufactur
instruct
invitrogen
hepg
cell
transient
transfect
constant
amount
vector
express
firefli
luciferas
basic
control
phrlcmv
vector
express
renilla
luciferas
intern
control
cell
split
plate
h
transfect
continu
cultur
day
compound
ad
medium
day
similar
antivir
assay
data
repres
averag
ae
standard
deviat
triplic
sampl
transcript
activ
determin
measur
luciferas
activ
multiwel
plate
luminomet
md
analyt
technolog
us
use
luciferas
report
assay
system
promega
hep
g
cell
cultur
medium
gibco
supplement
fetal
calf
serum
gibco
mgml
gibco
iuml
penicillin
gibco
iuml
streptomycin
gibco
maintain
c
moist
atmospher
contain
co
cell
subcultur
week
fresh
medium
ad
everi
day
male
femal
kunm
mice
ae
g
purchas
chengdu
dashuo
biotechnolog
co
ltd
chengdu
china
anim
certif
licens
scxk
chuan
randomli
divid
group
mice
male
plu
femal
group
mice
oral
administr
compound
singl
dose
blank
group
volum
physiolog
salin
mgkg
respect
mice
hous
free
access
water
food
stainless
cage
room
control
temperatur
ae
c
lightdark
cycl
mous
surviv
bodi
weight
monitor
record
day
posttreat
protocol
compli
guidelin
kunm
citi
laboratori
anim
administr
committe
china
care
use
laboratori
anim
